Literature DB >> 9231008

Prognostic factors in delayed ischaemic deficit with vasospasm in patients undergoing early aneurysm surgery.

M Shimoda1, S Oda, R Tsugane, O Sato.   

Abstract

We have examined prognostic factors in delayed ischaemic deficit attributed to vasospasm following subarachnoid haemorrhage (SAH) and early aneurysm surgery. Among 605 patients with SAH, 201 patients developed a delayed ischaemic deficit and 137 of these underwent early surgery. These 137 patients were classified into groups A and B by outcome at 3 months after SAH (group A: the delayed ischaemic deficit was associated with an adverse outcome; group B: no adverse outcome). Factors indicating an unfavourable outcome were as follows: (i) older age; (ii) poor WFNS grade on admission; (iii) Fisher's scale of 4; (iv) intracerebral haemorrhage; (v) delayed ischaemic deficit following rerupture; (vi) complications of surgical intervention; (vii) delayed ischaemic deficit with disturbance of consciousness; (viii) lack of immediate improvement with hypervolaemic therapy; and (ix) intracranial complications after hypervolaemic therapy. We suggest that the reversibility of a delayed ischaemic deficit is determined by preceding brain damage and/or surgical complications.

Entities:  

Mesh:

Year:  1997        PMID: 9231008     DOI: 10.1080/02688699746267

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  3 in total

1.  Treatment of ruptured intracranial aneurysms: report from a low-volume center.

Authors:  Gorazd Bunc; Janez Ravnik; Tomaz Seruga
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

2.  Fluid balance and blood volume measurement after aneurysmal subarachnoid hemorrhage.

Authors:  Reinier G Hoff; Gert W van Dijk; Ale Algra; Cor J Kalkman; Gabriel J E Rinkel
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

3.  Neurocritical care complications and interventions influence the outcome in aneurysmal subarachnoid hemorrhage.

Authors:  Alexander Hammer; Frank Erbguth; Matthias Hohenhaus; Christian M Hammer; Hannes Lücking; Markus Gesslein; Monika Killer-Oberpfalzer; Hans-Herbert Steiner; Hendrik Janssen
Journal:  BMC Neurol       Date:  2021-01-19       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.